🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Some experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to the social media company, the service has removed violative content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at residence.

After moments of entering one group, a seller posted contact information, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these groups, messages display black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially serious medical dangers”.